Quick Answer
MANGOCEUTICALS, INC. reported Net Income of -$8.71 million for fiscal year 2024.
MANGOCEUTICALS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$8.71M | +5.5% |
| 2023 | -$9.21M | -361.1% |
| 2022 | -$2.00M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.62M | -281.1% | -40.7% |
| June 30, 2025 | -$5.42M | -126.5% | -11.9% |
| March 31, 2025 | -$4.84M | -104.4% | -142.1% |
| September 30, 2024 | -$2.00M | -11.1% | +16.4% |
| June 30, 2024 | -$2.39M | -4.7% | -1.0% |
| March 31, 2024 | -$2.37M | +7.5% | -31.6% |
| September 30, 2023 | -$1.80M | -80.9% | +21.2% |
| June 30, 2023 | -$2.28M | -636.3% | +10.8% |
- MANGOCEUTICALS, INC. showed an increase of +5.5% in Net Income compared to the prior fiscal year.
- Over the 2022–2024 period, MANGOCEUTICALS, INC.’s net income has declined by 335.7% (from -$2.00 million to -$8.71 million).
- The most recent figure is from MANGOCEUTICALS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 20, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: